Cite
HARVARD Citation
Shanu-Wilson, J. et al. (n.d.). P10 - Use of microbial biotransformation to produce scalable quantities of a glucuronidated metabolite of the clinical-stage soluble guanylate cyclase inhibitor praliciguat. Drug metabolism and pharmacokinetics. pp. S25-. [Online].